Terazosin hydrochloride
- Level
- Commodity
- Parent
- 51263000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263010This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H25N5O4.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D32S14F082, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine but more generally known as terazosin hydrochloride, which bears US NIH Compound Identifier 5401. European Medicines Agency schedules Terazosin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04722MIG. Most nations, for tariff and trade purposes, schedule terazosin hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, TERAZOSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Terazosin hydrochloride bears US NLM identifiers UMLS ID C0770137 and NCI Concept Code C29491. SMILES: COC1CC2C(CC1OC)NC(NC2N)N3CCN(CC3)C(=O)C4CCCO4.O.O.CL.
Same parent
Under 51263000 · 17Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.